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Abstract
Introduction: In oral cavity, the tongue is the most common site prone to development of  squamous cell carcinoma 
(SCC). Considering malignant transformation as a cellular stress, the expression of heat shock proteins (HSPs) 
may be affected in this process. In this study we assessed the expression of HSP105 and HSP27 as two of the most 
interested stress proteins and investigated their relationship with grade and stage of the tongue SCC.
Material and Methods: Fifty-six specimens including 31 early and 25 advanced tongue SCC were gathered. �ll 
specimens were graded histologically from I to III. Sixteen sections of normal oral mucosa were used as control 
group. The cellularity and intensity of HSP105 and HSP27 expression were studied immunohistochemically in 
both case and control groups. Results were expressed by histochemical score (HSCORE).  
Results:  Significant differences were observed between expression of HSPs and stage of the disease. From early 
to advanced stage, the expression of HSP105 and HSP27 increased and decreased, respectively. There was no 
relationship between histological grade of lesion and HSCORE of HSP105 expression (P=0.5), although, HSP27 
expression had reverse relationship with the SCC histological grade.
Conclusion: HSP27 and HSP105 may be indicated for prognostic purposes in evaluation of tongue SCC. HSP 27 
may be used for more accurate microscopic grading of tongue SCC. Increased expression of HSP105 in advanced 
stage may lead to using this protein for immunotherapy of tongue SCC.
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Introduction
Squamous cell carcinoma (SCC) composes ninety-four 
percent of oral cavity carcinomas (1). Tongue cancer is 
the most common SCC of oral cavity with more ten-
dency for local invasion and spread (2).
General consensus states that accumulation of several 
genetic abnormalities in cells is required for malignant 
transformation (3). In current era of molecular pathol-
ogy; a myriad of oncogens including Ras, myc, c-erbB1; 
antiapoptotic proteins such as Bcl-x and Bcl-2; and sev-
eral tumor suppressor genes, the most eminent of them, 
P53, have been recognized in pathogenesis of oral carci-
nomas. However, the exact cause and effect mechanisms 
of them have not yet been fully elucidated (4).�nother 
group of proteins involved in malignant transformation 
are Heat Shock Proteins (HSPs). These proteins as of the 
most abundant intracellular substances are produced in 
response to different stresses including hyperthermia, 
heavy metals, oxygen free radicals, infections, inflam-
mation and ischemia (2-4).HSPs act as chaperones which 
protect unfolded or mal-folded proteins from destruction 
(5) and conduct them toward organelles to help in repair-
ing mal-folded proteins .If this cascade is not efficient, 
they mark the abnormal proteins for destruction in pro-
teosome complex (6) and if defective proteins accumu-
late, HSPs induce apoptosis for rapid elimination of these 
abnormal structures (7). HSPs can revive lost proteins by 
resynthesis and refolding denatured proteins (8) or other 
intracellular reactions (9). 
Recent discovery of the HSP family on the surface of 
malignant cells has led to proposing HSPs as tumoral 
antigens or carriers of such antigens (10,11).
HSP105, a high molecular weight mammalian stress 
protein belonging to HSP110 family, is released in re-
sponse to wide range of stress factors like heat, infec-
tion, ischemia, and tumors  (12,13).
It has two α and β isoforms, former is produced in both 
physiologic and pathologic conditions but latter, is ex-
clusively constructed during heat stress (14).
 HSP105 is normally bound to P53 in cytoplasm and 
inhibits P53 induced apoptosis. Heat stimulates HSP105 
to separate from P53 and its transportation to the nu-
cleus leading to apoptosis (15).
HSP27 is a low molecular weight protein which con-
tributes to heat tolerance and other cellular functions 
including signal transduction, differentiation, prolif-
eration, and cellular movement   (16). It is involved in 
keratinocyte differentiation and epidermis development 
(17) and works as chaperone for keratinization. This cy-
toplasmic marker is present in granular and spinosum 
layers of normal epidermis (18). 
The association of HSP27 Overexpression and survival 
rate of non-small cell lung cancer patients has been dem-
onstrated (19). In skin cancers, squamous cell carcinoma 
(SCC) which is more aggressive and has more propensity 
to develop metastasis than basal cell carcinoma (BCC) 
expresses HSP 105 marker much more intense than BCC 
(20), on the other hand HSP 27 is not expressed in SCC 
which is attributed to its aggressive nature (4). 
HSPs have become a target of interest for cancer im-
munotherapy. Immunization of some murine tumors 
by autologus HSPs has slowed the tumor progression 
and reduced metastasis rate (21). This study aimed at 
determining the correlation between the expression of 
HSP 105 and HSP 27 and their relationship with grade 
and stage in tongue SCC. The findings, when supported 
by other studies may be of prognostic and therapeutic 
value. This is the first study performed on HSP 105 in 
tongue SCC and its correlation with clinicopathologic 
indices. Here, mean number of the cells positive for 
HSP 105 and HSP 27 along with their intensity of ex-
pression in epithelial cells are obtained using immuno-
histochemistry (IHC); In addition, these two properties 
are merged by expressing them as histochemical score 
(HSCORE) for each grade and stage.
Material and Methods
In this retrospective study, we collected profile records 
along with pathology blocks of patients with tongue 
SCC referred to a teaching hospital in Mashhad, Iran 
from September 1994 to May 2009. Treatment protocol 
for patients with SCC of tongue was surgery and modi-
fied radical neck dissection and adjuvant radiotherapy if 
needed. Patients underwent tumor surgery without cer-
vical lymph node dissection and patients who received 
neoadjuvant treatment were excluded from the study 
due to uncertainty about the stage of the disease. There-
fore some cases were excluded due to the fact that some 
physicians in few years ago did not consider modified 
radical neck dissection in stage I tumors. Moreover, 
specimens with low quality, inappropriate fixation, or 
necrotic or bloody areas were also excluded.
Thirty-one patients were in early stages (I and II) and 
25 patients were in advanced stage (III) and 16 patients 
were healthy controls. Stages of the tumor were classi-
fied according to the TNM system.  Histological grad-
ing (I, II and III) was according to WHO classification 
(22).The study protocol was approved by the Ethical 
Committee of the Faculty of Dentistry.
Mean number of HSP 27 and HSP 105 positive cells and 
their intensity of expression in epithelial cells were in-
vestigated by IHC. 
Immunohistochemistry:
Four-μm serial sections from each formalin-fixed, 
paraffin-embedded blocks were cut. IHC was then per-
formed on sections fixed on poly-L-lysine-coated glass 
slides. Deparaffinized and rehydrated slides were in-
cubated for 30 minutes in 3% H2O2/methanol to stop 
endogenous peroxidase activity, and then irrigated with 
phosphate-buffered saline (PBS) for 20 minutes. Speci-
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mens were incubated with the primary anti-HSP27 
monoclonal antibody (Catologue No. Clone 2B4; Novo-
castra Laboratories Ltd,Newcastle, U.K.)  and primary 
anti-HSP27 monoclonal antibody (Catologue No. Clone 
58 F12; Novocastra Laboratories Ltd,Newcastle, U.K.). 
The slides were incubated for one hour in room tem-
perature. The sections were rinsed three times with PBS 
at room temperature. The secondary antibody was ap-
plied to treat immune complexes. Immune complexes 
were identified by streptavidin peroxidase (Novo Link 
Polymer detection system). �fter three times washing 
with PBS, the immunoreactivity was visualized by di-
aminobenzidine and hydrogen peroxide. The procedure 
was followed by counterstaining with hematoxylin and 
then slides examined by light microscopy. Epithelial 
cells were counted with light microscope at hot spot in 
five areas at 100X and 400X magnification. The areas 
were marked by highlighter pens to prevent counting 
one area twice. The density of stained cells for HSP105 
and HSP 27 markers was recorded as: 0: negative or low 
staining, 1: distinct staining, 2: strong staining.
The mean HSCORE and the percent of Overexpres-
sion were applied to express the severity of malignancy. 
HSCORE was estimated as follows: HSCORE = Pi (i + 
1), in which Pi (calculated percentage of stained tumor 
cells) ranged from 0 to 100% and intensity of stained 
epithelial cells (i) was 0, 1 or 2 as mentioned above. 
Overexpression of HSP27 or HSP 105 was defined by 
the mean HSCORE of 100. Positive control cases were 
retrieved from normal testis tissue for HSP 105 and nor-
mal skin tissues for HSP 27.
The results were analyzed using Statistical Package of 
Social Sciences software version 16.0 (SPSS, Chicago, 
Ill). ). HSP 105 and HSP 27 expression and the intensity 
of their staining on epithelial cells were compared by 
nonparametric Mann–Whitney and Kruskal–Wallis as 
well as Fisher’s exact tests. � P value less than 0.05 was 
considered statistically significant.
Results 
The mean age of patients with histological grades 
I, II and III of SCC was 62 ±14.8, 55.22 ±16.24, and 
60.17±16.19 years, respectively. (Table 1) and (Table 
2) illustrate the mean number of HSP 105 and HSP 27 
positive cells, intensity of their expression in epithelial 
cells and evaluation their HSCORE and overexpression 
in specimens of SCC with various histological grading 
(I, II, III) and stage (early, advanced) and control group. 
There was no statistically significant relationship be-
tween age and histological grade. Differences between 
Mean 
number of 
HSP 105 
positive cells 
P value 
Intensity of HSP105 expression in 
epithelial cells (%) P value
HSCORE for HSP105 
evaluation P value
- + ++ Mean Percent of Over expression (%)  
Basal layer 100 
P<0.00
- 18.7 (n=3) 81.3 (n=13) 
P= 0.14 
281±40          100 
P<0.00Spinusom layer 20±15 25 (n=4) 18.7 (n=3) 56.3 (n=9)  56±47 25 
Grade I 77±25 
P=0.25
-  51.8 (n=14) 48.2 (n=13) 
P=0.2
197±83    81.5 
P=0.15Grade II 73±32 - 33.3 (n=8) 66.7 (n=15)    201±103   73.9 
Grade III 96±5 - 14.3 (n=1) 85.7 (n=5) 275±48           100 
Early stage 62±28 P<0.00 -  67.7 (n=21) 32.3 (n=10) P=0.01 145±77  64.5 P=0.00�dvanced stage 97±4 - 8 (n=2) 92 (n=23) 283±28           100 
Mean 
number of 
HSP 27 
positive cells 
P value 
Intensity of HSP27 expression in 
epithelial cells (%) 
P value
HSCORE for HSP27 
evaluation
P value _
+ ++ Mean 
Percent of Over 
expression (%) 
Basal layer 25±10 
P<0.001 
31.3 (n=5)   25 (n=4) 43.8 (n=7) 
P=0.1
70±8 25 
P=0.01
Spinusom layer 84±25   6.3 (n=1)   25 (n=4)   68.8 (n=11) 231±86 94 
Grade I 90±12 
P=0.01
- 37 (n=10)   63 (n=17) 
P=0.4
238±63 100 
P=0.03Grade II 73±28 -   47.8 (n=11)   52.2 (n=12)  196±101  74 
Grade III 60±28 - 33.3 (n=4) 66.7 (n=2) 143±86   83.3 
Early stage        96±6 
P<0.001 
-   9.7 (n=3)   90.3 (n=28) 
P<0.001 
 278±35 100 
P<0.001 
�dvanced stage 60±24 - 12 (n=22)   88 (n=3)  128±53  72 
Table 1. HSP105 expression profile in different grades and stages of tongue squamous cell carcinoma.
Table 2. HSP27 expression profile in different grades and stages of tongue squamous cell carcinoma.
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patients’ age and tumor stages were remarkable (P= 
0.02).  There was no significant relation between sex 
and, histological grade and stage, HSCORE of HSP 27 
and HSP 105. Histological views of the specimens stud-
ied by IHC are seen in (Figs. 1 to 3).
Discussion 
The tongue is the most common site of oral cavity SCC. 
Its incidence has been increased two-fold among elder 
people whereas about five-fold in young people. The 
Determination of histological grade of SCC is to great 
extent a subjective issue depending on the assessment of 
pathologist and the location of biopsy (23).
To reach a more reliable conclusion we selected only 
tongue SCCs to prevent confounding of the results by 
using specimens from different parts of oral cavity. 
The study of Muchemwa et al. (20) was the first report 
in which the expression of HSP105 was evaluated by 
means of HSCORE in skin cancers including 23 SCCs 
and 23 basal cell carcinomas. HSCORE ≥ 100 was de-
fined as Overexpression and 60% and 100% of primary 
and metastatic SCCs over expressed HSP105, respec-
tively. By contrast, only 13% of basal cell carcinomas 
which are relatively benign slow growing tumors with 
low chance of metastasis showed such biologic behav-
ior. 
Suzuki et al. (6), studied expression of HSP27 in oral 
SCCs (30 well, 5 moderately and 2 poorly differenti-
ated specimens as well as 5 normal control from oral 
mucosa). Staining intensity in tumoral cells increased 
from basal layer toward the surface which is compatible 
with our findings. In contrast to our results, there was 
no relationship between stage and grade of the tumors 
and HSP27 expression. This discrepancy is perhaps due 
to the large differences among the number of samples in 
different groups in that study.
Mese et al. (24) also did not find any relationship be-
tween stage and grade of the tumors and HSP27 expres-
sion; the confounding factor could be the selection of 
samples from different locations of oral cavity.
In another study, there was significant relationship be-
tween HSP27 expression with histological grade and 
clinical stage of oral SCCs but not with gender which 
both are in agreement with our findings (22). �lso, Hus-
seiny, et al. (25) suggested no relationship between stage 
and grade with gender.   
Romanucci et al. (18) studied the expression of HSP27 
in SCCs of skin and detected more expression of this 
marker in well differentiated SCCs compared with 
moderately differentiated specimens; �lso, staining 
intensity for HSP27 was intensified in spinosum layer 
compared with basal layer. Similar to our findings, For-
tin, et al. (26) showed weak expression of HSP27 in ad-
vanced stages of oropharyngeal carcinomas. �lso, Ka-
wanishi, et al. (27) investigated the expression of HSP 
27 and HSP105 in 102 specimens of esophageal SCCs 
and recognized these two as valuable prognostic mark-
ers. They suggested that HSP27 is strongly associated 
with clinicopathologic characteristics and its expression 
is in reverse relationship with clinical stage which all 
agrees with our results. �bove mentioned findings show 
Fig. 1. HSP105 expression in advanced SCC, grade II, with 2nd de-
gree staining intensity and 100% cellularity (×100).
Fig. 2. HSP105 expression in early stage SCC, grade I, with 1nd 
degree staining intensity and 30% cellularity (×100).
Fig. 3. Cytoplasmic HSP27 expression in early stage SCC, grade I, 
with 2nd degree staining intensity and 100% cellularity (�: ×100, 
B: ×400).
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a similarity between SCC behaviors in different tissues 
which necessitate more scrutiny on molecular biology 
of this malignancy which perhaps yields some key in-
formation applicable to a myriad of neoplasms. 
On the other hand Nakajima, et al. (28) found no rela-
tionship between the rate of HSP27 expression and his-
tological grading in esophageal SCCs which may lead 
us to conclude that tumors with identical pathology may 
express different biologic behaviors when emerge in dif-
ferent tissues, although in that study, the increased HSP 
expression had been associated with lymphocyte infil-
tration and consequently accelerated immune response. 
Moreover, that study concluded that reduction in HSP27 
expression had been recognized as an indicative of tu-
mor progression and stage rising. In practical view, im-
munization with HSP 105 extracted from bone marrow 
dendritic cells in mice with multiple experimentally 
created adenomas significantly reduced the number of 
small intestinal polyps which is promising for employ-
ing this protein in cancer immunotherapy (29). 
Direct relationship of HSP105 and inverse relationship 
of HSP27 expression with stage of tongue SCC indicates 
their prognostic value. The high rate of HSP 27 expres-
sion in spinosum layer in control group (93.75%) com-
pared with basal layer suggests that HSP27 is a marker 
for keratinocyte differentiation. HSP 27 may be used for 
better histological grading of the tongue SCC. Progres-
sive increase in HSP105 expression from normal oral 
mucosa toward advanced tongue SCC postulates the 
idea of association of this marker with the lesion stage 
and worse prognosis. Pursuant to this concept, HSP27 
expression as a differentiation factor carries a better 
prognosis. Direct relationship between age and HSP105 
expression in tongue SCC suggests that with higher 
ages the protein folding mechanism in keratinocyes is 
interrupted in affected patients.  �nd last but not least, 
a statistically significant reverse relationship exists be-
tween HSP27 and HSP105 expression in tongue SCC.
Similar studies are encouraged for better understanding 
biologic behaviors of neoplasms which can potentially 
lead to development of novel curative techniques against 
them such as immunotherapy or recombinant DN� vac-
cines against different HSPs or other biological markers 
involved in neoplastic transformations. 
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